Key result
Antiarrhythmic drugs can paradoxically cause or worsen arrhythmias, demanding careful benefit-to-risk assessment before initiation.
Why the study?
Antiarrhythmic drugs may paradoxically exacerbate arrhythmias or cause more serious forms, and predicting proarrhythmic risk is essential for benefit/risk assessment.
Antiarrhythmic drugs carry a risk of proarrhythmia, requiring careful risk-benefit assessment based on drug class, arrhythmia type, and underlying left ventricular dysfunction.
No takes yet. Share an insight, caveat, or question.
Supports cautious AAD prescribing amid proarrhythmia risk; leaves open refined patient selection criteria for future studies.
Joel Morganroth (1992) conducted a review in Arrhythmia. Antiarrhythmic drugs was evaluated on Proarrhythmia. Antiarrhythmic drugs can paradoxically exacerbate arrhythmias or cause new ones, requiring careful assessment of the benefit-to-risk ratio before initiating therapy.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: